Cargando…
Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY
Autores principales: | Zacharopoulou, Eirini, Orfanoudaki, Eleni, Kitsou, Vassiliki, Tzouvala, Maria, Tribonias, George, Mantzaris, Gerassimos J., Viazis, Nikos, Christidou, Angeliki, Georgiadi, Tereza, Karmiris, Konstantinos, Theodoropoulou, Angeliki, Tsafaridou, Maria, Michopoulos, Spyridon, Zampeli, Evanthia, Papathanasiou, Evgenia, Michalopoulos, Georgios, Tigkas, Stefanos, Karatzas, Pantelis, Laoudi, Effrosyni, Liatsos, Christos, Kyriakos, Nikolaos, Mylonas, Iordanis, Theocharis, Georgios J., Kafentzi, Theodora, Koutroubakis, Ioannis E., Bamias, Giorgos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212535/ http://dx.doi.org/10.1016/S0016-5085(22)62389-8 |
Ejemplares similares
-
Real-World Use and Adverse Events of SARS-CoV-2 Vaccination in Greek Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2022) -
Tu1550: REAL WORLD USE AND ADVERSE EVENTS OF SARS-COV-2 VACCINATION IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Orfanoudaki, Eleni, et al.
Publicado: (2022) -
The Effect of Early vs Delayed Initiation of Adalimumab on Remission Rates in Patients With Crohn’s Disease With Poor Prognostic Factors: The MODIFY Study
por: Mantzaris, Gerassimos J, et al.
Publicado: (2021) -
The natural history of COVID-19 in vaccinated inflammatory bowel disease patients
por: Viazis, N., et al.
Publicado: (2023) -
The Inflammatory Bowel Disease—Disk Tool for Assessing Disability in Inflammatory Bowel Disease Patients: Validation of the Greek Version
por: Katsoula, Anastasia, et al.
Publicado: (2023)